Marathon Wealth Advisors LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Buy
4,978
+25
+0.5% +$25.5K 2.04% 19
2026
Q1
$4.56M Buy
4,953
+118
+2% +$120K 1.87% 20
2025
Q4
$5.2M Buy
+4,835
New +$4.62M 2.06% 17

Other funds holding LLY

Marathon Wealth Advisors LLC's LLY Position: Q2 2026 in Review

Marathon Wealth Advisors LLC increased its Eli Lilly (LLY) stake by 0.5% in Q2 2026, buying an estimated $25.5K and bringing the position to 4,978 shares worth $5.97M. The position accounts for 2.04% of the portfolio, ranked #19.

Marathon Wealth Advisors LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marathon Wealth Advisors LLC held 4,978 shares of Eli Lilly worth $5.97M as of Q2 2026.
  • Marathon Wealth Advisors LLC bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 2.04% of Marathon Wealth Advisors LLC's portfolio in Q2 2026, its #19 holding.
  • Marathon Wealth Advisors LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marathon Wealth Advisors LLC's 13F filing for Q2 2026, filed 11 Sep 2026.